JP2008535927A5 - - Google Patents

Download PDF

Info

Publication number
JP2008535927A5
JP2008535927A5 JP2008506677A JP2008506677A JP2008535927A5 JP 2008535927 A5 JP2008535927 A5 JP 2008535927A5 JP 2008506677 A JP2008506677 A JP 2008506677A JP 2008506677 A JP2008506677 A JP 2008506677A JP 2008535927 A5 JP2008535927 A5 JP 2008535927A5
Authority
JP
Japan
Prior art keywords
demethoxygeldanamycin
aminoethyl
micelles
loaded
days
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008506677A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008535927A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/013800 external-priority patent/WO2006110862A2/en
Publication of JP2008535927A publication Critical patent/JP2008535927A/ja
Publication of JP2008535927A5 publication Critical patent/JP2008535927A5/ja
Pending legal-status Critical Current

Links

JP2008506677A 2005-04-12 2006-04-12 ポリマー及びパッセンジャー薬のミセル組成物 Pending JP2008535927A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67046005P 2005-04-12 2005-04-12
US71600005P 2005-09-09 2005-09-09
PCT/US2006/013800 WO2006110862A2 (en) 2005-04-12 2006-04-12 Micelle composition of polymer and passenger drug

Publications (2)

Publication Number Publication Date
JP2008535927A JP2008535927A (ja) 2008-09-04
JP2008535927A5 true JP2008535927A5 (cg-RX-API-DMAC10.html) 2008-12-25

Family

ID=37011968

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008506677A Pending JP2008535927A (ja) 2005-04-12 2006-04-12 ポリマー及びパッセンジャー薬のミセル組成物

Country Status (7)

Country Link
US (2) US8173167B2 (cg-RX-API-DMAC10.html)
EP (1) EP1871343A2 (cg-RX-API-DMAC10.html)
JP (1) JP2008535927A (cg-RX-API-DMAC10.html)
KR (1) KR20080009196A (cg-RX-API-DMAC10.html)
AU (1) AU2006235538A1 (cg-RX-API-DMAC10.html)
CA (1) CA2603987A1 (cg-RX-API-DMAC10.html)
WO (1) WO2006110862A2 (cg-RX-API-DMAC10.html)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003230761A1 (en) * 2002-03-29 2003-10-13 Abbott Laboratories Polymeric micelle formulations of hydrophobic compounds and methods
US20080082036A1 (en) * 2006-04-25 2008-04-03 Medtronic, Inc. Cerebrospinal fluid shunt having long term anti-occlusion agent delivery
US20100119529A1 (en) * 2006-05-12 2010-05-13 Furgeson Darin Y Elastin-like polymer delivery vehicles
DE102006038233A1 (de) * 2006-08-07 2008-02-14 Biotronik Vi Patent Ag Markerkomposit für medizinische Implantate
US20080102127A1 (en) * 2006-10-26 2008-05-01 Gao Hai Y Hybrid lipid-polymer nanoparticulate delivery composition
US20080248097A1 (en) * 2007-02-26 2008-10-09 Kwon Glen S Polymeric micelles for combination drug delivery
WO2009006311A2 (en) * 2007-06-29 2009-01-08 Wisconsin Alumni Research Foundation Structuring effect of cholesterol in peg-phospholipid micelles, drug delivery of amphotericin b, and combination antifungals
WO2009009067A2 (en) * 2007-07-09 2009-01-15 Kwon Glen S Micelle encapsulation of theropeutic agents
US9422234B2 (en) * 2007-11-30 2016-08-23 The Johns Hopkins University Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer
US20090209757A1 (en) * 2008-01-10 2009-08-20 Santiago Ini Processes for the preparation and purification of paliperidone palmitate
US20090232762A1 (en) * 2008-03-11 2009-09-17 May Pang Xiong Compositions for delivery of therapeutic agents
US9271929B2 (en) * 2008-11-25 2016-03-01 École Polytechnique Fédérale De Lausanne (Epfl) Block copolymers and uses thereof
EP2419136A4 (en) * 2009-04-16 2013-01-02 Merck Sharp & Dohme COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER
WO2010140869A2 (en) * 2009-06-05 2010-12-09 Iljin Copper Foil Co., Ltd. Complex, multilayer using the same, and device coated with the multilayer
WO2011038278A2 (en) 2009-09-25 2011-03-31 Wisconsin Alumni Research Foundation Micelle encapsulation of therapeutic agents
US9283211B1 (en) 2009-11-11 2016-03-15 Rapamycin Holdings, Llc Oral rapamycin preparation and use for stomatitis
WO2015161139A1 (en) 2014-04-16 2015-10-22 Rapamycin Holdings, Llc Oral rapamycin preparation and use for stomatitis
US10391059B2 (en) 2009-11-11 2019-08-27 Rapamycin Holdings, Inc. Oral rapamycin nanoparticle preparations and use
AU2016202636B2 (en) * 2009-12-30 2017-06-08 Caliber Therapeutics, Llc Balloon catheter systems for delivery of dry drug delivery vesicles to a vessel in the body
KR101267813B1 (ko) * 2009-12-30 2013-06-04 주식회사 삼양바이오팜 향상된 수용해도를 갖는 라파마이신 함유 고분자나노입자 주사제형 조성물 및 그 제조방법, 및 방사선 요법과 병용하기 위한 항암 조성물
ES2845398T3 (es) * 2009-12-30 2021-07-26 Caliber Therapeutics Llc Sistemas de catéter de balón para administración de vesículas de administración de fármacos secos a un vaso en el cuerpo
EP2382966A1 (en) * 2010-03-12 2011-11-02 DSM IP Assets B.V. Micelle compositions and process for the preparation thereof
CN107320734A (zh) 2011-04-29 2017-11-07 西莱克塔生物科技公司 从合成纳米载体中控制释放免疫抑制剂
WO2012151544A1 (en) 2011-05-05 2012-11-08 Wisconsin Alumni Research Foundation Micelles for the solubilization of gossypol
CN102293736B (zh) * 2011-08-31 2013-06-05 兰州大学 紫杉醇-聚合物载药胶束制备工艺
JP2013203680A (ja) * 2012-03-28 2013-10-07 Kobe Gakuin ビタミンｅ誘導体を含有する血中滞留性薬物キャリアー粒子
US10172796B2 (en) 2012-12-03 2019-01-08 Manli International Ltd. Use of umirolimus and its derivatives for treating cancer
JP2016503012A (ja) 2012-12-12 2016-02-01 ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 化合物相互作用ドメインを含む製剤及びキャリアシステム
CN103142479A (zh) * 2013-03-29 2013-06-12 中国药科大学 一种磷脂-维生素e琥珀酸聚乙二醇酯胶束的应用
CN105307641A (zh) 2013-05-03 2016-02-03 西莱克塔生物科技公司 用于降低不期望体液免疫应答的给药组合
US10682415B2 (en) 2013-07-22 2020-06-16 Wisconsin Alumni Research Foundation Thermogel formulation for combination drug delivery
WO2015013510A1 (en) 2013-07-25 2015-01-29 Ecole Polytechnique Federale De Lausanne Epfl High aspect ratio nanofibril materials
US9700544B2 (en) * 2013-12-31 2017-07-11 Neal K Vail Oral rapamycin nanoparticle preparations
HUP1400075A2 (hu) 2014-02-14 2015-08-28 Druggability Technologies Ip Holdco Jersey Ltd Sirolimus és származékainak komplexei, elõállítása és gyógyszerészeti kompozíciói
US9855341B2 (en) 2014-02-19 2018-01-02 University of Pittsburgh—of the Commonwealth System of Higher Education Formulations and carrier systems including farnesylthiosalycylic moities
WO2016004369A1 (en) 2014-07-02 2016-01-07 The Research Foundation For The State University Of New York Surfactant-stripped micelle compositions with high cargo to surfactant ratio
EA201790551A1 (ru) 2014-09-07 2017-07-31 Селекта Байосайенсиз, Инк. Способы и композиции для ослабления иммунных ответов к пропускающему экзон вирусному трансферному вектору
US11633355B2 (en) 2014-12-12 2023-04-25 Clemson University Research Foundation Multi-functional particles and methods of using the same
US10232050B1 (en) 2014-12-12 2019-03-19 Clemson University Multi-functional particles and methods of using the same
SG10201912394VA (en) * 2015-07-15 2020-02-27 Celator Pharmaceuticals Inc Improved nanoparticle delivery systems
CN105232459B (zh) * 2015-09-24 2018-10-16 沈阳药科大学 一种复溶自组装的水难溶性药物聚合物胶束组合物及其制备方法
EP4599848A3 (en) 2017-03-11 2025-12-03 Cartesian Therapeutics, Inc. Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant
US20190029970A1 (en) * 2017-07-31 2019-01-31 The Chinese University Of Hong Kong Fatty acid conjugated nanoparticles and uses thereof
WO2019204799A1 (en) 2018-04-20 2019-10-24 University Of Pittsburgh -Of The Commonwealth System Of Higher Education Cationic amphiphilic polymers for codelivery of hydrophobic agents and nucleic acids
CN112823000A (zh) 2018-10-12 2021-05-18 联邦高等教育系统匹兹堡大学 用于试剂递送的小聚合物载体
KR102051593B1 (ko) 2018-11-15 2020-01-08 재단법인대구경북과학기술원 이중 반응형 양친매성 화합물, 이의 제조방법 및 이를 이용한 약물 전달체
US12553041B2 (en) 2019-06-04 2026-02-17 Cartesian Therapeutics Inc. Formulations and doses of pegylated uricase
CN111358754A (zh) * 2020-03-13 2020-07-03 广州白云山汉方现代药业有限公司 一种大环内酯类抗生素长循环乳剂及其制备方法
IT202000007228A1 (it) * 2020-04-06 2021-10-06 Diego Dolcetta SOMMINISTRAZIONE DI INIBITORI DI mTOR NEL SISTEMA NERVOSO CENTRALE
KR102701406B1 (ko) * 2021-10-18 2024-08-30 재단법인대구경북과학기술원 토코페롤을 포함하는 활성 산소 반응형 믹토암 양친매성 화합물, 이의 제조 방법, 및 이를 이용한 약물 전달체
WO2025095862A1 (en) * 2023-10-30 2025-05-08 National University Of Singapore A composition, a method of making the composition and its uses thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090414A (en) * 1970-05-20 2000-07-18 Life Science Labs, Inc. Method and composition to reduce cancer incidence
US4261989A (en) 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
US5536729A (en) * 1993-09-30 1996-07-16 American Home Products Corporation Rapamycin formulations for oral administration
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
US6107332A (en) * 1995-09-12 2000-08-22 The Liposome Company, Inc. Hydrolysis-promoting hydrophobic taxane derivatives
DK1229030T3 (da) 1995-09-12 2006-02-13 Zeneus Pharma Ltd Hydrolysefremmende, hydrofobe taxanderivater
US6284267B1 (en) 1996-08-14 2001-09-04 Nutrimed Biotech Amphiphilic materials and liposome formulations thereof
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6322810B1 (en) 1997-07-14 2001-11-27 Hayat Alkan-Onyuksel Materials and methods for making improved micelle compositions
US6217886B1 (en) * 1997-07-14 2001-04-17 The Board Of Trustees Of The University Of Illinois Materials and methods for making improved micelle compositions
AU1678900A (en) * 1998-08-11 2000-03-06 All India Institute Of Medical Sciences A novel liposomal formulation useful in treatment of cancer and other proliferation diseases
US6469132B1 (en) 1999-05-05 2002-10-22 Mcgill University Diblock copolymer and use thereof in a micellar drug delivery system
AU2001258872C1 (en) * 2000-05-12 2005-05-26 Samyang Biopharmaceuticals Corporation Method for the preparation of polymeric micelle via phase separation of block copolymer
US6764507B2 (en) * 2000-10-16 2004-07-20 Conor Medsystems, Inc. Expandable medical device with improved spatial distribution
US8067032B2 (en) * 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
TWI246524B (en) * 2001-01-19 2006-01-01 Shearwater Corp Multi-arm block copolymers as drug delivery vehicles
WO2003002096A1 (en) 2001-06-28 2003-01-09 Wisconsin Alumni Research Foundation Methods and compositions for polyene antibiotics with reduced toxicity
US6872715B2 (en) * 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
WO2003105765A2 (en) 2002-06-12 2003-12-24 The Board Of Trustees Of The University Of Illinois Phospholipid micelles in liposomes as solubilizers for water-insoluble compounds
US20040116360A1 (en) 2002-10-15 2004-06-17 Kwon Glen S. Encapsulation and deaggregation of polyene antibiotics using poly(ethylene glycol)-phospholipid micelles
US20050026893A1 (en) 2003-05-30 2005-02-03 Kosan Biosciences, Inc. Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants
IL180785A (en) 2004-07-19 2014-03-31 Celator Pharmaceuticals Inc Preparations containing particulate structures for the release of active substances

Similar Documents

Publication Publication Date Title
ECSP088239A (es) Composición de liberación de fármaco sostenida
JP2009523455A5 (cg-RX-API-DMAC10.html)
JP2009545527A5 (cg-RX-API-DMAC10.html)
JP2008542211A5 (cg-RX-API-DMAC10.html)
CL2007001993A1 (es) Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat
WO2008122966A3 (en) A pharmaceutical composition of tacrolimus
ES2556585T3 (es) Composiciones que comprenden sulfato de salbutamol
CL2007002018A1 (es) Compuestos derivados de isoxazolinas sustituidas; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto para el tratamiento de una enfermedad causada por un aumento en la proliferacion celular.
JP2008543290A5 (cg-RX-API-DMAC10.html)
WO2009074351A3 (en) Solid forms of tenofovir disoproxil
JP2009511485A5 (cg-RX-API-DMAC10.html)
JP2008543729A5 (cg-RX-API-DMAC10.html)
JP2010532807A5 (cg-RX-API-DMAC10.html)
JP2009507826A5 (cg-RX-API-DMAC10.html)
DK2046292T3 (da) Formuleringer for benzimidazolylpyridylethere
JP2009520703A5 (cg-RX-API-DMAC10.html)
CL2007001752A1 (es) Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral.
IL191758A0 (en) Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof
JP2008533230A5 (cg-RX-API-DMAC10.html)
EP2468772A3 (en) Antibodies to EGFL7 and methods for their use
JP2007231207A5 (cg-RX-API-DMAC10.html)
JP2008543830A5 (cg-RX-API-DMAC10.html)
JP2007321035A5 (cg-RX-API-DMAC10.html)
JP2007500762A5 (cg-RX-API-DMAC10.html)
AR060869A1 (es) Composicion farmaceutica solida de gabapentina